Effective anti-PD-1 therapy reduces neutrophil infiltration via T cell-macrophage chemokine axis in hepatocellular carcinoma.
OBJECTIVE Immune checkpoint inhibitor (ICI) therapies, such as anti-PD-1 treatment, have achieved great success in various cancers, including hepatocellular carcinoma. Tumor-infiltrating lymphocytes have major roles in the mechanism of action for ICIs, but numerous other components of the tumor microenvironment also co...